(Q78454290)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12408995%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

title

Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12408995%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Ganoderma lucidum

1 reference

1 reference

Daniel Sliva

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12408995%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Carlos Labarrere

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12408995%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Veronika Slivova

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12408995%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Miroslav Sedlak

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12408995%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Frank P Lloyd

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12408995%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

Nancy W Y Ho

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12408995%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

publication date

1 November 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12408995%20AND%20SRC:MED&resulttype=core&format=json

Biochemical and Biophysical Research Communications

14 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12408995%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

volume

298

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12408995%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

page(s)

603-612

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12408995%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12408995%20AND%20SRC:MED&resulttype=core&format=json

Update from Asia. Asian studies on cancer chemoprevention

14 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

A mushroom fruiting body-inducing substance inhibits activities of replicative DNA polymerases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

The biochemistry of cancer dissemination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

The urokinase-type plasminogen activator system in cancer metastasis: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Autocrine activities of basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Antibodies to plasminogen activator inhibit human tumor metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

The urokinase plasminogen activator receptor (uPAR) as a target for the diagnosis and therapy of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

7 January 2021

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Regulation of urokinase-type plasminogen activator expression by an ERK1-dependent signaling pathway in a squamous cell carcinoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Enhancement of the migration of metastatic human breast cancer cells by phosphatidic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Counting actively metabolizing tissue cultured cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Tip60 interacts with human interleukin-9 receptor alpha-chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

The NF-kappa B and I kappa B proteins: new discoveries and insights

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Dimerization of the N-terminal amphipathic alpha-helix domain of the fungal immunomodulatory protein from Ganoderma tsugae (Fip-gts) defined by a yeast two-hybrid system and site-directed mutagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Natural inhibitors for protein prenyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Ganoderma extract activates MAP kinases and induces the neuronal differentiation of rat pheochromocytoma PC12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

AP-1 blockade inhibits the growth of normal and malignant breast cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Distinct roles of the Ikappa B kinase alpha and beta subunits in liberating nuclear factor kappa B (NF-kappa B) from Ikappa B and in phosphorylating the p65 subunit of NF-kappa B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Role of herbal compounds (PC-SPES) in hormone-refractory prostate cancer: two case reports.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902496-8

10.1016/S0006-291X(02)02496-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12408995%20AND%20SRC:MED&resulttype=core&format=json

14 December 2019

1 reference